Javascript must be enabled to continue!
The impact of transcatheter tricuspid valve replacement on right ventricular function
View through CrossRef
Abstract
Background
Transcatheter tricuspid valve replacement (TTVR) is increasingly used as a therapy option for patients with severe tricuspid regurgitation (TR) who are ineliglibe for heart surgery.[1] Previous studies revealed that impaired right ventricular dysfunction was an independent negative predictor of the clinical success.[2] However, the impact of the TTVR on the right ventricular function remains unknown.
Purpose
The aim of this study was to analyze the acute and chronic changes in the right ventricular function after the TTVR.
Methods
All patients undergoing TTVR using Evoque and LuxValve in a single tertiary center in Germany between 12/2023 and 07/2025 were included. The echocardiographic assessment was performed before TTVR, at discharge and by follow-up after 30-days. Right ventricular function was evaluated using tricuspid annular plane systolic excursion (TAPSE), right ventricular free wall strain (RV FWS), fractional area change (RV FAC) and peak systolic velocity of the right ventricle's tricuspid annulus with tissue Doppler imaging (RV S’). The statistical analysis was conducted using paired t-test.
Results
The study included 29 patients, with a median age of 74.8±7.3 years and 65.5% of them were women. Patients presented with severe (10.3%), massive (37.9%), and torrential (51.7%) TR at baseline. Right ventricular function was mildly impaired prior to TTVR (Table 1.). Our analysis revealed that TAPSE, FAC and RV FWS were significantly reduced directly after TTVR, whereas there was no significant change in RV S’. TAPSE reduction persisted at 30 days follow-up and RV S´ significantly decreased at 30-day follow-up. On the contrary, improvements were observed in the RV FWS and FAC after 30 days.
Conclusion
Right ventricular function is acutely reduced after TTVR. TAPSE and RV S’ remain persistently reduced after 30-days, however RV FWS and FAC revealed slight improvements during follow-up. How the observed changes in right ventricular function following TTVR impact clinical outcome and prognosis requires further study.For image description, please refer to the figure legend and surrounding text.
Oxford University Press (OUP)
Title: The impact of transcatheter tricuspid valve replacement on right ventricular function
Description:
Abstract
Background
Transcatheter tricuspid valve replacement (TTVR) is increasingly used as a therapy option for patients with severe tricuspid regurgitation (TR) who are ineliglibe for heart surgery.
[1] Previous studies revealed that impaired right ventricular dysfunction was an independent negative predictor of the clinical success.
[2] However, the impact of the TTVR on the right ventricular function remains unknown.
Purpose
The aim of this study was to analyze the acute and chronic changes in the right ventricular function after the TTVR.
Methods
All patients undergoing TTVR using Evoque and LuxValve in a single tertiary center in Germany between 12/2023 and 07/2025 were included.
The echocardiographic assessment was performed before TTVR, at discharge and by follow-up after 30-days.
Right ventricular function was evaluated using tricuspid annular plane systolic excursion (TAPSE), right ventricular free wall strain (RV FWS), fractional area change (RV FAC) and peak systolic velocity of the right ventricle's tricuspid annulus with tissue Doppler imaging (RV S’).
The statistical analysis was conducted using paired t-test.
Results
The study included 29 patients, with a median age of 74.
8±7.
3 years and 65.
5% of them were women.
Patients presented with severe (10.
3%), massive (37.
9%), and torrential (51.
7%) TR at baseline.
Right ventricular function was mildly impaired prior to TTVR (Table 1.
).
Our analysis revealed that TAPSE, FAC and RV FWS were significantly reduced directly after TTVR, whereas there was no significant change in RV S’.
TAPSE reduction persisted at 30 days follow-up and RV S´ significantly decreased at 30-day follow-up.
On the contrary, improvements were observed in the RV FWS and FAC after 30 days.
Conclusion
Right ventricular function is acutely reduced after TTVR.
TAPSE and RV S’ remain persistently reduced after 30-days, however RV FWS and FAC revealed slight improvements during follow-up.
How the observed changes in right ventricular function following TTVR impact clinical outcome and prognosis requires further study.
For image description, please refer to the figure legend and surrounding text.
Related Results
Redo isolated tricuspid valve replacement in a patient with isolated persistent left superior vena cava: a case report
Redo isolated tricuspid valve replacement in a patient with isolated persistent left superior vena cava: a case report
Abstract
Background
Redo isolated tricuspid valve surgery has high in-hospital mortality and morbidity and is a challenging procedure. We report a s...
Assessment of STS-TR score for transcatheter tricuspid valve interventions: an international multicenter study
Assessment of STS-TR score for transcatheter tricuspid valve interventions: an international multicenter study
Abstract
Background
Transcatheter tricuspid valve intervention (TTVI) is increasingly utilized for symptomatic severe tri...
Comparison of Valveplasty and Replacement for Surgical Treatment of Infective Tricuspid Valve Endocarditis
Comparison of Valveplasty and Replacement for Surgical Treatment of Infective Tricuspid Valve Endocarditis
Abstract
Background
In recent years, due to the increase in intravenous drug injection and intracardiac and vascular interventional treatments among drug users, infective ...
Comparison of Heart Valve Circumference Examined Before and After 10% Formalin Fixation
Comparison of Heart Valve Circumference Examined Before and After 10% Formalin Fixation
Objective: To compare the heart valve circumference before and after 10% formalin fixation. Materials and Methods: The study analyzed 63 Thai human cadaveric hearts. Each heart val...
A Novel Transcatheter Edge-to-Edge Suturing Technique and Prototype for Repairing Tricuspid Valve Regurgitation
A Novel Transcatheter Edge-to-Edge Suturing Technique and Prototype for Repairing Tricuspid Valve Regurgitation
Abstract
Tricuspid valve regurgitation is a major clinical issue that continues to attract interest from interventional cardiologists and medical device designers du...
New generation software for evaluation of annular dynamics and reverse remodeling after transcatheter repair in patients with severe atrial functional tricuspid regurgitation
New generation software for evaluation of annular dynamics and reverse remodeling after transcatheter repair in patients with severe atrial functional tricuspid regurgitation
Abstract
Introduction
Functional tricuspid regurgitation (fTR) is the most common cause of TR. The routine imaging method of the...
Abstract 4360971: Where Is My Valve? Three-Decade Survival for Tricuspid Valvectomy Without Valve Replacement Following Infective Endocarditis
Abstract 4360971: Where Is My Valve? Three-Decade Survival for Tricuspid Valvectomy Without Valve Replacement Following Infective Endocarditis
Background:
Amid the opioid pandemic, rising intravenous drug use (IVDU) has markedly increased the incidence of tricuspid valve endocarditis (TVE), a serious c...
The Critical Role of Presettable and Expandable Artificial Surgical Valves in the Lifetime Management of Valvular Heart Disease
The Critical Role of Presettable and Expandable Artificial Surgical Valves in the Lifetime Management of Valvular Heart Disease
With the trend of younger patients undergoing surgical valve replacement and increased life expectancy, how to account for subsequent therapies during the initial valve replacement...

